The PI3K pathway is frequently mutated in cancer, but inhibitors of this pathway have largely disappointed in the clinic. A new study, published in Nature, shows a keto diet dramatically sensitizes tumors to PI3K inhibitors in pre-clinical models.

The PI3K pathway is frequently mutated in cancer, but inhibitors of this pathway have largely disappointed in the clinic. A new study, published in Nature, shows a keto diet dramatically sensitizes tumors to PI3K inhibitors in pre-clinical models.: https://ift.tt/2lV3Njs Read more... https://ift.tt/2KxwQZb